Tamarack Advisers’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-125,000	Closed	-$1.61M	–	32
2023 Q2	$1.61M	Sell	125,000 -75,000	-38%	-$1.01M	0.5%	25
2023 Q1	$2.64M	Sell	200,000 -30,000	-13%	-$477K	0.96%	21
2022 Q4	$3.45M	Buy	230,000 +30,000	+15%	+$275K	1.78%	19
2022 Q3	$2.36M	Hold	200,000	–	–	1.39%	23
2022 Q2	$2.26M	Sell	200,000 -125,000	-38%	-$2.51M	1.31%	22
2022 Q1	$9.72M	Sell	325,000 -125,000	-28%	-$3.38M	4.6%	7
2021 Q4	$11.9M	Sell	450,000 -250,000	-36%	-$7.54M	4.9%	6
2021 Q3	$25.4M	Buy	700,000 +60,000	+9%	+$2.36M	8.02%	2
2021 Q2	$27.8M	Sell	640,000 -195,000	-23%	-$7.36M	7.87%	2
2021 Q1	$28.6M	Buy	835,000 +90,000	+12%	+$3.56M	5.86%	3
2020 Q4	$26M	Sell	745,000 -5,000	-0.7%	-$145K	5.41%	4
2020 Q3	$18M	Buy	750,000 +65,000	+9%	+$1.6M	5.55%	5
2020 Q2	$12.5M	Buy	685,000 +130,000	+23%	+$2.34M	3.49%	11
2020 Q1	$8.66M	Sell	555,000 -20,000	-3%	-$426K	3.28%	12
2019 Q4	$11.8M	Buy	575,000 +27,500	+5%	+$566K	2.69%	18
2019 Q3	$10.2M	Hold	547,500	–	–	2.67%	12
2019 Q2	$14M	Buy	547,500 +17,500	+3%	+$395K	4.26%	10
2019 Q1	$13.6M	Sell	530,000 -20,000	-4%	-$457K	5.41%	7
2018 Q4	$12.7M	Buy	550,000 +95,000	+21%	+$2.68M	5.16%	10
2018 Q3	$14.6M	Buy	455,000 +192,500	+73%	+$5.78M	4.17%	9
2018 Q2	$7.43M	Buy	+262,500	New	+$9.34M	2.49%	15